| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S10238-014-0332-3 |
| P698 | PubMed publication ID | 25516467 |
| P2093 | author name string | Xiaorong Yang | |
| Dechun Zhang | |||
| Jinmei Yang | |||
| Shichao Li | |||
| Jiesheng Zhen | |||
| P2860 | cites work | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | Q50496294 |
| Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. | Q51535040 | ||
| A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study | Q74321041 | ||
| Evaluation of tumor markers in southern Indian breast cancer patients | Q84511235 | ||
| Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor | Q84963968 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
| Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis | Q27023210 | ||
| Viruses and human breast cancer | Q28238361 | ||
| Cancer treatment and survivorship statistics, 2014 | Q29617702 | ||
| Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data | Q30703091 | ||
| Meta-DiSc: a software for meta-analysis of test accuracy data. | Q31048578 | ||
| Incidence and mortality of female breast cancer in the Asia-Pacific region | Q33802497 | ||
| The diagnostic odds ratio: a single indicator of test performance | Q34276416 | ||
| Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis | Q34984342 | ||
| Advantages and Disadvantages of Mammography Screening | Q35095608 | ||
| Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients | Q35992891 | ||
| Serum tumor markers in breast cancer: are they of clinical value? | Q36367261 | ||
| Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer | Q36546638 | ||
| MicroRNAs as potential biomarkers in human solid tumors | Q36553661 | ||
| MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management | Q37068548 | ||
| MicroRNA-21 as a potential colon and rectal cancer biomarker | Q37162427 | ||
| Serum circulating microRNA profiling for identification of potential breast cancer biomarkers | Q37260646 | ||
| Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA | Q37413603 | ||
| MicroRNAs in breast cancer pathogenesis. | Q37809731 | ||
| MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer | Q37849967 | ||
| Breast cancer and microRNAs: therapeutic impact. | Q37947912 | ||
| Secretory miRNAs as novel cancer biomarkers | Q37996238 | ||
| Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases | Q38018832 | ||
| Circulating microRNAs as novel minimally invasive biomarkers for breast cancer | Q39281588 | ||
| Risk of breast cancer after false-positive test results in screening mammography | Q45070562 | ||
| Novel approaches to the diagnosis and treatment of breast cancer | Q48954451 | ||
| P433 | issue | 1 | |
| P921 | main subject | microRNA | Q310899 |
| meta-analysis | Q815382 | ||
| biomarker | Q864574 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 29-35 | |
| P577 | publication date | 2014-12-17 | |
| P1433 | published in | Clinical and Experimental Medicine | Q15753118 |
| P1476 | title | Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis | |
| P478 | volume | 16 |
| Q92708685 | An overview protocol of biomarkers for breast cancer detection |
| Q89908202 | Associations Between miRNAs and Two Different Cancers: Breast and Colon |
| Q39183771 | Biomarkers-A General Review |
| Q38369215 | Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles |
| Q36140281 | Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer |
| Q39415180 | Early Diagnosis of Breast Cancer |
| Q38971467 | Emerging role of microRNA-21 in cancer |
| Q39411607 | Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications |
| Q36324338 | Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker |
| Q39373193 | Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry |
| Q30239810 | Identification of Biomarkers for Breast Cancer Using Databases |
| Q27016123 | Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer |
| Q94940502 | Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers |
| Q37376319 | MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies |
| Q47947610 | MicroRNAs as biomarkers for clinical studies |
| Q99548917 | Milk Exosomes: Perspective Agents for Anticancer Drug Delivery |
| Q26801523 | Milk--A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation |
| Q60958994 | Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication |
| Q89967718 | Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection |
| Q39529523 | Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients |
| Q37243591 | Plasma exosome microRNAs are indicative of breast cancer |
| Q38967715 | Prognostic value of circulating microRNA-21 for breast cancer: a systematic review and meta-analysis |
| Q124832004 | RETRACTED: Potential biomarker for breast cancer screening: A systematic review and meta-analysis |
| Q91639221 | RNA-Seq Revealed Novel Non-proliferative Retinopathy Specific Circulating MiRNAs in T2DM Patients |
| Q42290908 | The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic condition |
| Q41346578 | Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer |
| Q92755500 | Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management |
Search more.